Objective: To evaluate the management of erectile dysfunction (ED) in chronic kidney failure (CKF) patients in Congo. Patients and method: This was a cross-sectional study with prospective data collection over a period of 9 months, carried out in the nephrology departments of three hospitals in Congo. The IIEF-5 score was used to assess erectile function. We included all CRD patients with ED over 18 years of age. Results: The mean age of the patients was 54.4±(range: 20 years and 81 years). Cardiovascular risk factors were dominated by high blood pressure which accounted for 86 patients (91.5%). BMI was normal in 76 patients (80%). Grade 2 hypertension was noted in 47 patients (49.47%). Two patients (2%) did not have secondary sexual characteristics. The average duration of CKF was 3 years. The onset of ED was preceded by CKF in 92 cases (96.8%). The onset of ED was gradual in 72 cases (78.2%). The circumstance of the occurrence of ED was found in five cases (5.2%). Penile stiffness was low in 86 cases (90.5%). Sixty-four patients (67.4%) did not have a nocturnal erection. Other associated sexual disorders were decreased libido in 46 cases (48.4%), anorgasmia in 53 cases (55.8%) and premature ejaculation in 47 cases (49.47%). The mean IIEF 5 score was 11.38±4.44. Erectile dysfunction was severe in 43 cases (45.2%). Examination of the penis was normal in all cases. Erectile dysfunction was difficult to bear in 51 cases (53.7%). The testosterone level was between 5.5-32 nmol / L in 44 patients (68.8%). FSH and LH levels were increased in 60% of cases. The prolactin level between 1.8 - 29.2 micrograms / l in 14 cases (70%). The medical treatment of erectile dysfunction concerned 36 patients (37.8%). Conclusion: ED has psychological consequences that accentuate the suffering of patients. Modification of these risk factors must be undertaken early. IPDE5 have improved the management of erectile dysfunction
| Published in | International Journal of Clinical Urology (Volume 6, Issue 1) |
| DOI | 10.11648/j.ijcu.20220601.12 |
| Page(s) | 5-9 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Chronic Kidney Failure, Erectile Dysfunction, Congo
| [1] | NIH consensus conference: Impotence. NIH Consensus Development Panel Impotence. JAMA, 1993; 270: 83-90. |
| [2] | Kleinclauss F, Kleinclauss C, Bittard H. Dysfonction érectile chez les patients insuffisants rénaux et transplantés rénaux. Prog urol 2005; 15: 447-55. |
| [3] | Droupy S. Épidémiologie et physiopathologie de la dysfonction érectile. annales d'urologie 2005; 39 (2): 71-8. |
| [4] | Diallo Y., Coume M., Ze Ondo C., et al. Dysfonction érectile: profil épidémiologique dans une population de sujets retraités au Sénégal. Andrologie (2012) 22: 241-245. |
| [5] | Amidu N, Owiredu WKBA, Woode E, et al. Prevalence of male sexual dysfunction among Ghanaian populace: myth or reality ? Int J of Impotence Research 2012; 22: 337-42. |
| [6] | Bouya A. P., Odzebe A. W. S., Mayala Maognan R., et al. La dysfonction érectile au Congo: premières données sur la fréquence de ce motif de consultation et profil clinique au centre hospitalier universitaire de Brazzaville. Andrologie 2012; 22: 92-95. |
| [7] | Akbari F., Alavi M., Esteghamati A., et al. Effect of renal transplantation on sperm quality and sex hormone levels. BJU Int., 2003; 92: 281-283. |
| [8] | Ayub W., Fletcher S.: End-stage renal disease and erectile dysfunction. Is there any hope. Nephrol. Dial. Transplant., 2000; 15: 1525-1528. |
| [9] | Oladiji F, Koyode OO, Parakoyi DB. Influence of sociodemographique caracteristic on prevalence of erectile dysfunction in Nigeria. Int J impot Res. 2013 janv; 25 (1): 18-23. |
| [10] | Baka KH, Moudouni SM, Sanda G, Sadiki B, Lakmichi AM. Prévalence de la dysfonction érectile en Urologie. African Journal of Urology (2017) 4: 349-13. |
| [11] | Badri M S. The Declaration of Helsinki on medical research involving human subjects: a review of seventh revision (Medical Education). Journal of Nepal Health Research Council January 2020, 17 (4): 548-552. |
| [12] | Rosen RC, Riley A, Wagner G et al.: The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49 (6): 822-830. |
| [13] | Costa MR, Reis AM, Pereira BP, et al. Associated factors and prevalence of erectile dysfunction in hemodialysis patients. In Braz J Urol 2014; 40 (1): 44-45. |
| [14] | Oueslati I, Ounissi M, Azaiez S, et al. Prévalence et facteurs de risque de la dysfonction érectile chez l’insuffisants rénaux chroniques. African Journal of Urology (2017) 23, 331-337. |
| [15] | Azemar MD, Menard J, Ripert T, et al. Le schéma thérapeutique habituel de la dysfonction érectile est-il adapté après 65 ans ? Prog Urol (2009) 19: 202–8. |
| [16] | Diao B, Ndoye AK, Fall PA, et al. Dysfonction érectile au Sénégal: profil épidémiologique. Androl. 2007; 17 (3): 223-229. |
| [17] | PALMER B. F.: Sexual dysfunction in uremia. J. Am. Soc. Nephrol., 1999; 10: 1381-1388.38. |
| [18] | Peskircioglu L, Tekin MI, Demirag A, et al. Evaluation of erectile function in renal transplant recipients. Transplant Proc. 1998; 30: 747-749. |
| [19] | Phé V, Rouprêt M, Ferhi K, et al. Étiologie et prise en charge de la dysfonction érectile chez le patient diabétique. Progurol 2009; 19: 3-71. |
| [20] | Chen J., Mabjeesh N. J., Greenstein A., et al. Clinical efficacy of sildenafil in patients on chronic dialysis. J. Urol., 2001; 165: 819-821. |
| [21] | Seibel I., Poli De Figueiredo C. E., Teloken C., et al. Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J. Am. Soc. Nephrol., 2002; 13: 2770-2775. |
| [22] | Turk S., Karalezli G., Tonbul H. Z., et al. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant., 2001; 16: 1818-1822. |
| [23] | Ernst E., Pittler M. H. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J. Urol., 1998; 159: 433-436. |
APA Style
Armel Melvin Ondongo Atipo, Steve Aristide Ondziel-Opara, Daniel Tony Sinomono Eyeni, Gabriel Aime Ossombo, Roland Bertile Banga Mouss, et al. (2022). Management of Erectile Dysfunction in Chronic Kidney Failure in Congo. International Journal of Clinical Urology, 6(1), 5-9. https://doi.org/10.11648/j.ijcu.20220601.12
ACS Style
Armel Melvin Ondongo Atipo; Steve Aristide Ondziel-Opara; Daniel Tony Sinomono Eyeni; Gabriel Aime Ossombo; Roland Bertile Banga Mouss, et al. Management of Erectile Dysfunction in Chronic Kidney Failure in Congo. Int. J. Clin. Urol. 2022, 6(1), 5-9. doi: 10.11648/j.ijcu.20220601.12
AMA Style
Armel Melvin Ondongo Atipo, Steve Aristide Ondziel-Opara, Daniel Tony Sinomono Eyeni, Gabriel Aime Ossombo, Roland Bertile Banga Mouss, et al. Management of Erectile Dysfunction in Chronic Kidney Failure in Congo. Int J Clin Urol. 2022;6(1):5-9. doi: 10.11648/j.ijcu.20220601.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcu.20220601.12,
author = {Armel Melvin Ondongo Atipo and Steve Aristide Ondziel-Opara and Daniel Tony Sinomono Eyeni and Gabriel Aime Ossombo and Roland Bertile Banga Mouss and Yannick Dimi Nyanga and Anani Wencesl Severin Odzebe and Prosper Alain Bouya},
title = {Management of Erectile Dysfunction in Chronic Kidney Failure in Congo},
journal = {International Journal of Clinical Urology},
volume = {6},
number = {1},
pages = {5-9},
doi = {10.11648/j.ijcu.20220601.12},
url = {https://doi.org/10.11648/j.ijcu.20220601.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20220601.12},
abstract = {Objective: To evaluate the management of erectile dysfunction (ED) in chronic kidney failure (CKF) patients in Congo. Patients and method: This was a cross-sectional study with prospective data collection over a period of 9 months, carried out in the nephrology departments of three hospitals in Congo. The IIEF-5 score was used to assess erectile function. We included all CRD patients with ED over 18 years of age. Results: The mean age of the patients was 54.4±(range: 20 years and 81 years). Cardiovascular risk factors were dominated by high blood pressure which accounted for 86 patients (91.5%). BMI was normal in 76 patients (80%). Grade 2 hypertension was noted in 47 patients (49.47%). Two patients (2%) did not have secondary sexual characteristics. The average duration of CKF was 3 years. The onset of ED was preceded by CKF in 92 cases (96.8%). The onset of ED was gradual in 72 cases (78.2%). The circumstance of the occurrence of ED was found in five cases (5.2%). Penile stiffness was low in 86 cases (90.5%). Sixty-four patients (67.4%) did not have a nocturnal erection. Other associated sexual disorders were decreased libido in 46 cases (48.4%), anorgasmia in 53 cases (55.8%) and premature ejaculation in 47 cases (49.47%). The mean IIEF 5 score was 11.38±4.44. Erectile dysfunction was severe in 43 cases (45.2%). Examination of the penis was normal in all cases. Erectile dysfunction was difficult to bear in 51 cases (53.7%). The testosterone level was between 5.5-32 nmol / L in 44 patients (68.8%). FSH and LH levels were increased in 60% of cases. The prolactin level between 1.8 - 29.2 micrograms / l in 14 cases (70%). The medical treatment of erectile dysfunction concerned 36 patients (37.8%). Conclusion: ED has psychological consequences that accentuate the suffering of patients. Modification of these risk factors must be undertaken early. IPDE5 have improved the management of erectile dysfunction},
year = {2022}
}
TY - JOUR T1 - Management of Erectile Dysfunction in Chronic Kidney Failure in Congo AU - Armel Melvin Ondongo Atipo AU - Steve Aristide Ondziel-Opara AU - Daniel Tony Sinomono Eyeni AU - Gabriel Aime Ossombo AU - Roland Bertile Banga Mouss AU - Yannick Dimi Nyanga AU - Anani Wencesl Severin Odzebe AU - Prosper Alain Bouya Y1 - 2022/01/17 PY - 2022 N1 - https://doi.org/10.11648/j.ijcu.20220601.12 DO - 10.11648/j.ijcu.20220601.12 T2 - International Journal of Clinical Urology JF - International Journal of Clinical Urology JO - International Journal of Clinical Urology SP - 5 EP - 9 PB - Science Publishing Group SN - 2640-1355 UR - https://doi.org/10.11648/j.ijcu.20220601.12 AB - Objective: To evaluate the management of erectile dysfunction (ED) in chronic kidney failure (CKF) patients in Congo. Patients and method: This was a cross-sectional study with prospective data collection over a period of 9 months, carried out in the nephrology departments of three hospitals in Congo. The IIEF-5 score was used to assess erectile function. We included all CRD patients with ED over 18 years of age. Results: The mean age of the patients was 54.4±(range: 20 years and 81 years). Cardiovascular risk factors were dominated by high blood pressure which accounted for 86 patients (91.5%). BMI was normal in 76 patients (80%). Grade 2 hypertension was noted in 47 patients (49.47%). Two patients (2%) did not have secondary sexual characteristics. The average duration of CKF was 3 years. The onset of ED was preceded by CKF in 92 cases (96.8%). The onset of ED was gradual in 72 cases (78.2%). The circumstance of the occurrence of ED was found in five cases (5.2%). Penile stiffness was low in 86 cases (90.5%). Sixty-four patients (67.4%) did not have a nocturnal erection. Other associated sexual disorders were decreased libido in 46 cases (48.4%), anorgasmia in 53 cases (55.8%) and premature ejaculation in 47 cases (49.47%). The mean IIEF 5 score was 11.38±4.44. Erectile dysfunction was severe in 43 cases (45.2%). Examination of the penis was normal in all cases. Erectile dysfunction was difficult to bear in 51 cases (53.7%). The testosterone level was between 5.5-32 nmol / L in 44 patients (68.8%). FSH and LH levels were increased in 60% of cases. The prolactin level between 1.8 - 29.2 micrograms / l in 14 cases (70%). The medical treatment of erectile dysfunction concerned 36 patients (37.8%). Conclusion: ED has psychological consequences that accentuate the suffering of patients. Modification of these risk factors must be undertaken early. IPDE5 have improved the management of erectile dysfunction VL - 6 IS - 1 ER -
Information
Email: